Agilent Technologies, Inc. (A) Earnings

Agilent Technologies, Inc.

A · NYSE

Jul 2026upcoming

Next quarter

Consensus is $1.48 EPS for Jul 2026 across 6 estimates, ranging $1.43 to $1.50.

A Apr 2026

Reported May 27, 2026

Beat 6.43%

EPS estimate: $1.40
EPS actual: $1.49
Revenue estimate: —
Revenue actual: —
1-day move: +16.87%

Call highlights have not been generated for this quarter.

Symbol: A
Type: Stock
Sector: Industrials
Industry: Biotechnology: Laboratory Analytical Instruments
Country: North America
Exchange: NYSE

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com.

Key Issues

Bullish view

The primary consensus is Buy across 17 analysts, with a mean target of $155 versus the supplied $139.20 closing price. Barclays also raised its target to $150 while retaining Overweight.

Bearish view

The target range is unusually wide where disclosed: Citigroup's $185 target contrasts with Oppenheimer's $90 target. That dispersion indicates substantial disagreement about Agilent's valuation and prospective performance.

Analyst Consensus

See all

Buy

17 analysts

$141

Current

—

Low

$155

Average

—

High

Average target implies +9.80% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Teva Pharmaceutical Industries Limited American Depositary Shares